NCT01924624 Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT01923233 In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT01918683 TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT01914263 Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection Status UNKNOWN Phase PHASE1
NCT01908426 Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib Status COMPLETED Phase PHASE3
NCT01901692 Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion Status COMPLETED Phase PHASE2/PHASE3
NCT01894269 Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication Status UNKNOWN Phase PHASE4
NCT01892072 VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway Status UNKNOWN Phase N/A
NCT01890291 Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients. Status COMPLETED Phase N/A
NCT01887717 Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein Status TERMINATED Phase PHASE3
NCT01875549 Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent Status WITHDRAWN Phase NA
NCT01872988 Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma Status TERMINATED Phase PHASE3
NCT01871545 Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) Status COMPLETED Phase NA
NCT01869088 TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma Status UNKNOWN Phase PHASE3
NCT01858207 Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient Status UNKNOWN Phase PHASE2
NCT01857726 Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion Status WITHDRAWN Phase NA
NCT01853618 Tremelimumab With Chemoembolization or Ablation for Liver Cancer Status COMPLETED Phase PHASE1/PHASE2